| Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease | Alzheimer's and Dementia | 2011 | 4.2K |
| Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease | Nature Genetics | 2011 | 1.4K |
| Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease | Nature | 2011 | 1.3K |
| New definition for periprosthetic joint infection: from the Workgroup of the Musculoskeletal Infection Society | Clinical Orthopaedics and Related Research | 2011 | 1.1K |
| Medication adherence: WHO cares? | Mayo Clinic Proceedings | 2011 | 1K |
| Conservation of resource caravans and engaged settings | Journal of Occupational and Organizational Psychology | 2011 | 628 |
| The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's disease | Movement Disorders | 2011 | 599 |
| APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy | Journal of the American Society of Nephrology: JASN | 2011 | 540 |
| MDS Task Force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCI | Movement Disorders | 2011 | 527 |
| Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson's disease | PLoS ONE | 2011 | 483 |
| Phase I study of Navitoclax (ABT-263), a novel Bcl-2 family inhibitor, in patients with small-cell lung cancer and other solid tumors | Journal of Clinical Oncology | 2011 | 424 |
| Post-traumatic osteoarthritis: improved understanding and opportunities for early intervention | Journal of Orthopaedic Research | 2011 | 410 |
| The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease | Movement Disorders | 2011 | 397 |
| Identification of a central role for complement in osteoarthritis | Nature Medicine | 2011 | 378 |
| 5-Hydroxymethylcytosine is strongly depleted in human cancers but its levels do not correlate with IDH1 mutations | Cancer Research | 2011 | 352 |
| Growth factor and catabolic cytokine concentrations are influenced by the cellular composition of platelet-rich plasma | American Journal of Sports Medicine | 2011 | 350 |
| Late-life social activity and cognitive decline in old age | Journal of the International Neuropsychological Society | 2011 | 327 |
| Trends in the incidence and prevalence of Alzheimer's disease, dementia, and cognitive impairment in the United States | Alzheimer's and Dementia | 2011 | 322 |
| Priorities in Parkinson's disease research | Nature Reviews Drug Discovery | 2011 | 317 |
| Guidelines of care for the management of primary cutaneous melanoma. American Academy of Dermatology | Journal of the American Academy of Dermatology | 2011 | 289 |
| Epigenetic modification of the FMR1 gene in fragile X syndrome is associated with differential response to the mGluR5 antagonist AFQ056 | Science Translational Medicine | 2011 | 287 |
| Ageing as a primary risk factor for Parkinson's disease: evidence from studies of non-human primates | Nature Reviews Neuroscience | 2011 | 285 |
| Functional links between Aβ toxicity, endocytic trafficking, and Alzheimer's disease risk factors in yeast | Science | 2011 | 279 |
| Adherence to a Mediterranean-type dietary pattern and cognitive decline in a community population | American Journal of Clinical Nutrition | 2011 | 276 |
| Microinfarct pathology, dementia, and cognitive systems | Stroke | 2011 | 269 |
